{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:00:21Z","timestamp":1764046821017,"version":"3.37.3"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T00:00:00Z","timestamp":1586563200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801600","81601400"],"award-info":[{"award-number":["81801600","81601400"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program","award":["18YF1414500"],"award-info":[{"award-number":["18YF1414500"]}]},{"name":"Shanghai Jiao Tong University Medicine-Engineering Cross-disciplinary Research Foundation","award":["YG2016QN62"],"award-info":[{"award-number":["YG2016QN62"]}]},{"name":"Guangci Distinguished Young Scholars Training Program","award":["GCQN-2017-B04"],"award-info":[{"award-number":["GCQN-2017-B04"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Triggering receptor expressed on myeloid cells-1 (TREM-1) is an amplifier of inflammatory signals. Recently, a soluble form of TREM-1 (sTREM-1) was described. This study aimed to investigate the role of serum sTREM-1 in patients with adult-onset Still\u2019s disease (AOSD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Serum sTREM-1 levels were detected in 108 AOSD patients, 88 RA patients and 112 healthy controls (HC). The correlations of sTREM-1 with disease activity, clinical characteristics and laboratory parameters in AOSD patients were analysed by the Spearman correlation test. Risk factors for the chronic course of AOSD were evaluated by multivariate logistic regression analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>AOSD patients had significantly higher serum sTREM-1 levels than RA patients and HC, and serum sTREM-1 levels were correlated with the systemic score, ferritin, leucocyte count, CRP, IL-1\u03b2 and IL-6. The elevation in the initial sTREM-1 level by itself could discriminate patients developing the chronic course from patients developing the nonchronic course. Moreover, an elevated sTREM-1 level (&amp;gt; 526.4475\u2009pg\/ml) was an independent risk factor for the chronic course in active AOSD patients. Furthermore, interfering with TREM-1 engagement led to reductions in the secretion of pro-inflammatory cytokines, such as IL-1\u03b2, IL-6 and TNF-\u03b1, in neutrophils and monocytes from active AOSD patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Serum sTREM-1 levels are correlated with disease activity, and an elevation in the initial serum sTREM-1 level is a potential predictor of the chronic course in AOSD patients, which currently provides the best predictive model for identifying patients prone to developing the chronic course of AOSD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa135","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T12:23:59Z","timestamp":1582806239000},"page":"3293-3302","source":"Crossref","is-referenced-by-count":22,"title":["Serum sTREM-1 in adult-onset Still\u2019s disease: a novel biomarker of disease activity and a potential predictor of the chronic course"],"prefix":"10.1093","volume":"59","author":[{"given":"Zhihong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9587-1180","authenticated-orcid":false,"given":"Huihui","family":"Chi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Teng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tienan","family":"Feng","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobing","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junna","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongyi","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinchao","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuochao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengde","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0358-8933","authenticated-orcid":false,"given":"Yutong","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Ruijin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,4,10]]},"reference":[{"key":"2020102707110712200_keaa135-B1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2020102707110712200_keaa135-B2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still\u2019s disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2020102707110712200_keaa135-B3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780300209","article-title":"Adult-onset Still\u2019s disease. Clinical course and outcome","volume":"30","author":"Cush","year":"1987","journal-title":"Arthritis Rheum"},{"key":"2020102707110712200_keaa135-B4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ard.2005.042143","article-title":"Diagnosis and management of adult onset Still\u2019s disease","volume":"65","author":"Efthimiou","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2020102707110712200_keaa135-B5","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/art.27532","article-title":"Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still\u2019s disease","volume":"62","author":"Franchini","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2020102707110712200_keaa135-B6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/acr.22194","article-title":"Clinical manifestations of adult-onset Still\u2019s disease presenting with erosive arthritis: association with low levels of ferritin and interleukin-18","volume":"66","author":"Ichida","year":"2014","journal-title":"Arthritis Care Res"},{"key":"2020102707110712200_keaa135-B7","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/rheumatology\/40.12.1398","article-title":"Cytokine and immunogenetic profiles in Japanese patients with adult Still\u2019s disease. Association with chronic articular disease","volume":"40","author":"Fujii","year":"2001","journal-title":"Rheumatology"},{"key":"2020102707110712200_keaa135-B8","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","article-title":"Adult onset Still\u2019s disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions","volume":"13","author":"Maria","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2020102707110712200_keaa135-B9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12026-014-8561-9","article-title":"Pathogenesis of adult-onset Still\u2019s disease: new insights from the juvenile counterpart","volume":"61","author":"Jamilloux","year":"2015","journal-title":"Immunol Res"},{"key":"2020102707110712200_keaa135-B10","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3390\/ijms17081342","article-title":"TLR4 endogenous ligand S100A8\/A9 levels in adult-onset still\u2019s disease and their association with disease activity and clinical manifestations","volume":"17","author":"Kim","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2020102707110712200_keaa135-B11","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar4193","article-title":"Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still\u2019s disease","volume":"15","author":"Chen","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2020102707110712200_keaa135-B12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13075-018-1800-z","article-title":"Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still\u2019s disease","volume":"21","author":"Hu","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2020102707110712200_keaa135-B13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nri1106","article-title":"TREMs in the immune system and beyond","volume":"3","author":"Colonna","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"2020102707110712200_keaa135-B14","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ni1411","article-title":"The TREM receptor family and signal integration","volume":"7","author":"Klesney-Tait","year":"2006","journal-title":"Nat Immunol"},{"key":"2020102707110712200_keaa135-B15","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","article-title":"Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes","volume":"164","author":"Bouchon","year":"2000","journal-title":"J Immunol"},{"key":"2020102707110712200_keaa135-B16","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/35074114","article-title":"TREM-1 amplifies inflammation and is a crucial mediator of septic shock","volume":"410","author":"Bouchon","year":"2001","journal-title":"Nature"},{"key":"2020102707110712200_keaa135-B17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.imlet.2007.11.021","article-title":"The TREM-1\/DAP12 pathway","volume":"116","author":"Tessarz","year":"2008","journal-title":"Immunol Lett"},{"key":"2020102707110712200_keaa135-B18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1084\/jem.20040708","article-title":"A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis","volume":"200","author":"Gibot","year":"2004","journal-title":"J Exp Med"},{"key":"2020102707110712200_keaa135-B19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-141-1-200407060-00009","article-title":"Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis","volume":"141","author":"Gibot","year":"2004","journal-title":"Ann Int Med"},{"key":"2020102707110712200_keaa135-B20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa031544","article-title":"Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia","volume":"350","author":"Gibot","year":"2004","journal-title":"N Engl J Med"},{"key":"2020102707110712200_keaa135-B21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/eci.12442","article-title":"Soluble triggering receptor expressed on myeloid cells-1 is a biomarker of anti-CCP-positive, early rheumatoid arthritis","volume":"45","author":"Molad","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"2020102707110712200_keaa135-B22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/08820139.2016.1211140","article-title":"Clinical association of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in patients with systemic lupus erythematosus","volume":"46","author":"Bassyouni","year":"2017","journal-title":"Immunol Invest"},{"key":"2020102707110712200_keaa135-B23","first-page":"1846","article-title":"Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a new mediator involved in early ankylosing spondylitis","volume":"35","author":"Chen","year":"2008","journal-title":"J Rheumatol"},{"key":"2020102707110712200_keaa135-B24","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s10620-008-0514-5","article-title":"Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease","volume":"54","author":"Park","year":"2009","journal-title":"Dig Dis Sci"},{"key":"2020102707110712200_keaa135-B25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.dld.2012.05.011","article-title":"Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases","volume":"44","author":"Jung","year":"2012","journal-title":"Dig Liver Dis"},{"key":"2020102707110712200_keaa135-B26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/1753425919870847","article-title":"In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosis","volume":"25","author":"Gorlier","year":"2019","journal-title":"Innate Immun"},{"key":"2020102707110712200_keaa135-B27","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"2020102707110712200_keaa135-B28","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2020102707110712200_keaa135-B29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine"},{"key":"2020102707110712200_keaa135-B30","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3899\/jrheum.111500","article-title":"Natural killer cell cytolytic function in Korean patients with adult-onset Still\u2019s disease","volume":"39","author":"Park","year":"2012","journal-title":"J Rheumatol"},{"key":"2020102707110712200_keaa135-B31","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1172\/JCI30602","article-title":"TREM-1\u2013expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases","volume":"117","author":"Schenk","year":"2007","journal-title":"J Clin Invest"},{"key":"2020102707110712200_keaa135-B32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2017.02.043","article-title":"TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives","volume":"177","author":"Tammaro","year":"2017","journal-title":"Pharmacol Ther"},{"key":"2020102707110712200_keaa135-B33","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.4049\/jimmunol.179.6.4065","article-title":"Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes","volume":"179","author":"Gomez-Pina","year":"2007","journal-title":"J Immunol"},{"key":"2020102707110712200_keaa135-B34","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/gutjnl-2017-315494","article-title":"Cell-centred meta-analysis reveals baseline predictors of anti-TNFalpha non-response in biopsy and blood of patients with IBD","volume":"68","author":"Gaujoux","year":"2019","journal-title":"Gut"},{"key":"2020102707110712200_keaa135-B35","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ebiom.2019.01.027","article-title":"Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease","volume":"40","author":"Verstockt","year":"2019","journal-title":"EBioMedicine"},{"key":"2020102707110712200_keaa135-B36","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","article-title":"Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis","volume":"49","author":"Shimizu","year":"2010","journal-title":"Rheumatology"},{"key":"2020102707110712200_keaa135-B37","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/art.24554","article-title":"Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis","volume":"60","author":"Murakami","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2020102707110712200_keaa135-B38","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/cvr\/cvy018","article-title":"Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock","volume":"114","author":"Jolly","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2020102707110712200_keaa135-B39","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1158\/0008-5472.CAN-12-0938","article-title":"The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma","volume":"72","author":"Wu","year":"2012","journal-title":"Cancer Res"},{"key":"2020102707110712200_keaa135-B40","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s10067-016-3314-x","article-title":"Elevated high-mobility group B1 levels in active adult-onset Still\u2019s disease associated with systemic score and skin rash","volume":"35","author":"Jung","year":"2016","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/11\/3293\/34038222\/keaa135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/11\/3293\/34038222\/keaa135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T11:53:15Z","timestamp":1603799595000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/11\/3293\/5818944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,10]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,4,10]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa135","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"type":"print","value":"1462-0324"},{"type":"electronic","value":"1462-0332"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,4,10]]}}}